Advertisement
Research Article

Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World

  • Laurens M. Niëns mail,

    niens@bmg.eur.nl

    Affiliation: Institute for Medical Technology Assessment and Institute for Health Policy & Management, Erasmus University Rotterdam, The Netherlands

    X
  • Alexandra Cameron,

    Affiliation: Essential Medicines and Pharmaceutical Policies, World Health Organization, Geneva, Switzerland

    X
  • Ellen Van de Poel,

    Affiliation: Institute for Medical Technology Assessment and Institute for Health Policy & Management, Erasmus University Rotterdam, The Netherlands

    X
  • Margaret Ewen,

    Affiliation: Health Action International Global, Amsterdam, The Netherlands

    X
  • Werner B. F. Brouwer,

    Affiliation: Institute for Medical Technology Assessment and Institute for Health Policy & Management, Erasmus University Rotterdam, The Netherlands

    X
  • Richard Laing

    Affiliation: Essential Medicines and Pharmaceutical Policies, World Health Organization, Geneva, Switzerland

    X
  • Published: August 31, 2010
  • DOI: 10.1371/journal.pmed.1000333

Reader Comments (2)

Post a new comment on this article

Publisher's Note: Minor Correction

Posted by plosmedicine on 08 Sep 2010 at 14:26 GMT

Percentage of the population below the poverty line before procurement of the medicines and the population drawn below the poverty line by expenditures on these medicines.
http://plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000333#pmed-1000333-t003

Minor Corrections to Table 3:

The title of Table 3 should read:

'Percentage of the population below the poverty line before and after procurement of the medicines.'

The one-line footer of Table 3 ("The sum of both gives the proportion of the population for which the medicine is unaffordable") should be omitted.

No competing interests declared.